Runben Biotechnology Co., Ltd. (SHA:603193)

China · Delayed Price · Currency is CNY

20.87

+0.22 (1.07%)

Jun 18, 2026, 11:29 AM CST

-39.23% (1Y)

Market Cap	8.35B -48.1%
Revenue (ttm)	1.57B +13.0%
Net Income	322.94M +4.6%
EPS	0.80 +5.5%
Shares Out	404.59M
PE Ratio	25.83
Forward PE	22.20
Dividend	0.46 (2.18%)
Ex-Dividend Date	May 29, 2026

Volume	1,509,071
Open	20.65
Previous Close	20.65
Day's Range	20.40 - 21.16
52-Week Range	20.28 - 37.15
Beta	0.23
Analysts	Strong Buy
Price Target	32.98 (+58.03%)
Earnings Date	Aug 14, 2026

About Runben Biotechnology

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China.Runben Biotechnology Co., Ltd. operates as a subsidiary of Guangzhou Zhuofan Investment Holding Co., Ltd [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 1993

Employees 1,018

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603193

Full Company Profile

Financial Performance

In 2025, Runben Biotechnology's revenue was 1.54 billion, an increase of 17.19% compared to the previous year's 1.32 billion. Earnings were 314.50 million, an increase of 4.78%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 603193 stock is "Strong Buy." The 12-month stock price target is ¥32.98, which is an increase of 58.03% from the latest price.

Price Target

¥32.98

(58.03% upside)

Analyst Consensus: Strong Buy

Stock Forecasts